Mach7 Technologies (ASX:M7T), a medical imaging software company, is a turnaround under new leadership, according to Katana Asset Management. In April 2026, Katana said Mach7's new CEO is turning the company around, noting it will take time but offers large upside if executed successfully. In January, Katana reported Mach7 fell late in the month after announcing the end of a complex, lower-margin contract, and in December noted its first meaningful new contract in several years. Katana describes Mach7 as its preferred ASX PACS company. Mach7 Technologies operates in the Healthcare sector within the Health Care Technology industry, and Thesis Tracker has captured 4 comments from 1 fund manager, Katana Asset Management. Founded in 2007 and headquartered in Melbourne, Mach7 develops enterprise imaging software, including vendor-neutral archives and diagnostic viewers, for hospitals and health systems in North America and Asia Pacific.